Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice

Table 5 Rates of antipsychotics and antidepressants in BPD (2008–2012)

	admission N = 30	discharge N = 40	Fisher’s exact (p value)
low-potency antipsychotics	53,3	42,5	0.4693
high-potency antipsychotics	0	5
second-generation antipsychotics	60	60	1.0000
	admission N = 44	discharge N = 59	Fisher’s exact (p value)
tri−/tetracyclic antidepressants	13.6	13.6	1.0000
SSRI	52.3	55.9	0.8417
MAO inhibitors	2.3	0
atypical antidepressants	31.8	42.4	0.3096

Rates in %; N number of patients receiving antipsychotics (upper section) or antidepressants (lower section); reference = N; Bonferroni correction for antipsychotics (p < 0.016), for antidepressants (p < 0.0125)

ISSN: 1471-244X